0001104659-21-010411.txt : 20210201 0001104659-21-010411.hdr.sgml : 20210201 20210201205416 ACCESSION NUMBER: 0001104659-21-010411 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210128 FILED AS OF DATE: 20210201 DATE AS OF CHANGE: 20210201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZACCARDELLI DAVID CENTRAL INDEX KEY: 0001627642 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38067 FILM NUMBER: 21578595 MAIL ADDRESS: STREET 1: 300 TRI STATE INTERNATIONAL STREET 2: SUITE 272 CITY: LINCOLNSHIRE STATE: IL ZIP: 60069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Verona Pharma plc CENTRAL INDEX KEY: 0001657312 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE BUSINESS PHONE: 011-44-0-2032834200 MAIL ADDRESS: STREET 1: 3 MORE LONDON RIVERSIDE CITY: LONDON STATE: X0 ZIP: SE1 2RE 4 1 tm214905-2_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-01-28 0 0001657312 Verona Pharma plc VRNA 0001627642 ZACCARDELLI DAVID 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE UNITED KINGDOM 1 1 0 0 President and CEO Ordinary Shares 2021-01-28 4 A 0 529104 0 A 20094240 D Reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer. Consists of (i) 19,201,992 Ordinary Shares underlying Restricted Share Units, each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer (which are represented by 2,400,249 ADSs); and (ii) 892,248 Ordinary Shares represented by 111,531 ADSs. /s/ Claire Poll, Attorney-in-fact for David Zaccardelli 2021-02-01